Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Sep 29, 2025 → Sep 29, 2029
See other at-risk trials from Columbia University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Sep 29, 2025 to Sep 29, 2029 Show 4 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Study completion pushed from Sep 29, 2026 to Sep 29, 2029
    • Eligibility criteria expanded, about 6 words
    • Publications: details revised at 25 of 25 entries
  2. Study completion date: Sep 29, 2025 to Sep 29, 2026
    • Publications: 24 to 25
    v8
  3. Publications: 23 to 24v7
  4. Primary and study completion dates: Sep 29, 2024 to Sep 29, 2025v6
  5. Publications: 18 to 23v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Recruiting to Active, Not Recruitingv3 Show 6 more changesShow less
    • Enrollment target: estimated 2373 to confirmed 749
    • Primary and study completion dates: Sep 2024 to Sep 29, 2024
    • Site details revised
    • Publications: 15 to 18
    • Eligibility criteria expanded, about 5 words
    • Study title expanded, about 1 word
  3. Site contact updated
    • Eligibility criteria expanded, about 5 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Columbia University
305 trials monitored
See 27 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New York City residents living in affordable housing buildings in Harlem and Washington Heights.
Trial Details
NCT Number NCT04271709
Lead Sponsor Columbia University
Collaborators: Centers for Disease Control and Prevention
Conditions
(from sponsor)		 Glaucoma, Vision Impairment and Blindness, Cataract, Diabetic Retinopathy, Eye Diseases
Related terms Blindness, Cataract, Diabetic Retinopathy, Eye Diseases, Glaucoma, Vision Disorders
Enrollment 749 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov